These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36502414)

  • 21. The United States President's Emergency Plan for AIDS Relief: a story of partnerships and smart investments to turn the tide of the global AIDS pandemic.
    Goosby E; Dybul M; Fauci AS; Fu J; Walsh T; Needle R; Bouey P
    J Acquir Immune Defic Syndr; 2012 Aug; 60 Suppl 3():S51-6. PubMed ID: 22797740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protecting the gains: analysis of HIV treatment and service delivery programme data and interventions implemented in 19 African countries during COVID-19.
    Bachanas PJ; Chun HM; Mehta N; Aberle-Grasse J; Parris K; Sherlock MW; Lloyd S; Zeh C; Makwepa DK; Kapanda ML; Dokubo EK; Bonono L; Balachandra S; Ehui E; Fonjungo P; Nkoso AM; Mazibuko S; Okello VN; Tefera F; Getachew M; Katiku EM; Mulwa A; Asiimwe FM; Tarumbiswa TF; Auld AF; Nyirenda R; Dos Santos De Louvado AP; Gaspar I; Hong SY; Ashipala L; Obanubi C; Ikpeazu A; Musoni C; Yoboka E; Mthethwa S; Pinini Z; Bunga S; Rumunu J; Magesa DJ; Mutayoba B; Nelson LJ; Katureebe C; Agolory S; Mulenga LB; Nyika P; Mugurungi O; Ellerbrock T; Mitruka K
    J Int AIDS Soc; 2022 Nov; 25(11):e26033. PubMed ID: 36419346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Partnerships, Collaborations, and Investments Integral to CDC's International Response to COVID-19.
    Walensky RP
    Emerg Infect Dis; 2022 Dec; 28(13):S1-S3. PubMed ID: 36496350
    [No Abstract]   [Full Text] [Related]  

  • 24. Monitoring the quality of SARS-CoV-2 virus detection in molecular diagnostic laboratories in the Eastern Mediterranean Region during the COVID-19 pandemic.
    Meredith LW; Aboualy M; Ochola R; Ozel M; Abubakar A; Barakat A
    Influenza Other Respir Viruses; 2023 Nov; 17(11):e13217. PubMed ID: 38019698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Global Responses to the COVID-19 Pandemic.
    Cassell CH; Raghunathan PL; Henao O; Pappas-DeLuca KA; Rémy WL; Dokubo EK; Merrill RD; Marston BJ
    Emerg Infect Dis; 2022 Dec; 28(13):S4-S7. PubMed ID: 36502408
    [No Abstract]   [Full Text] [Related]  

  • 26. Lessons from Nigeria's Adaptation of Global Health Initiatives during the COVID-19 Pandemic.
    Ihekweazu C
    Emerg Infect Dis; 2022 Dec; 28(13):S299-S301. PubMed ID: 36502443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delayed Laboratory Response to COVID-19 Caused by Molecular Diagnostic Contamination.
    Mögling R; Meijer A; Berginc N; Bruisten S; Charrel R; Coutard B; Eckerle I; Enouf V; Hungnes O; Korukluoglu G; Kossyvakis T; Mentis A; Molenkamp R; Muradrasoli S; Papa A; Pigny F; Thirion L; van der Werf S; Reusken C
    Emerg Infect Dis; 2020 Aug; 26(8):1944-1946. PubMed ID: 32433015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concurrent Testing for COVID-19 and HIV Infection at 6 High-Volume Emergency Departments in a Priority Jurisdiction for Ending the HIV Epidemic in the United States.
    McNulty MC; Stanford KA; Eller D; Sha BE; Purim-Shem-Tov Y; Kishen E; Glick N; Hunt B; Lin JY; Maheswaran A; Galvin S; Turelli R; Schmitt J; Pitrak D
    J Acquir Immune Defic Syndr; 2023 Dec; 94(4):364-370. PubMed ID: 37884056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Pandemic within Other Pandemics. When a Multiple Infection of a Host Occurs: SARS-CoV-2, HIV and
    González-Domenech CM; Pérez-Hernández I; Gómez-Ayerbe C; Viciana Ramos I; Palacios-Muñoz R; Santos J
    Viruses; 2021 May; 13(5):. PubMed ID: 34067925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparedness of European diagnostic microbiology labs for detection of SARS-CoV-2, March 2020.
    Matheeussen V; Loens K; Lammens C; Vilken T; Koopmans M; Goossens H; Ieven M;
    J Clin Virol; 2020 Jul; 128():104432. PubMed ID: 32422569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. International external quality assessment for SARS-CoV-2 molecular detection and survey on clinical laboratory preparedness during the COVID-19 pandemic, April/May 2020.
    Matheeussen V; Corman VM; Donoso Mantke O; McCulloch E; Lammens C; Goossens H; Niemeyer D; Wallace PS; Klapper P; Niesters HG; Drosten C; Ieven M;
    Euro Surveill; 2020 Jul; 25(27):. PubMed ID: 32672149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Experience of Testing for Coronavirus Disease (COVID-19) at a Single Diagnostic Center in Paraguay before the Introduction of Vaccination.
    del-Puerto F; Rojas LE; Díaz Acosta CC; Franco LX; Cardozo F; Galeano ME; Valenzuela A; Rojas A; Martínez M; Ayala-Lugo A; Mendoza L; Ovando FS; Martínez MF; Chung HJ; Webby R; Nara E; Caniza MA
    Viruses; 2023 May; 15(5):. PubMed ID: 37243222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mapping the impact of the expanded Mexico City Policy for HIV/ family planning service integration in PEPFAR-supported countries: a risk index.
    Sherwood J; Sharp A; Honermann B; Horrigan C; Chatterjee M; Jones A; Cooney C; Millett G
    BMC Public Health; 2018 Sep; 18(1):1116. PubMed ID: 30208876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early trends for SARS-CoV-2 infection in central and north Texas and impact on other circulating respiratory viruses.
    Mutnal MB; Arroliga AC; Walker K; Mohammad A; Brigmon MM; Beaver RM; Midturi JK; Rao A
    J Med Virol; 2020 Oct; 92(10):2130-2138. PubMed ID: 32410236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measuring training effectiveness of laboratory biosafety program offered at African Center for Integrated Laboratory Training in 22 President's Emergency Plan for AIDS Relief supported countries (2008-2014).
    Shrivastava R; Stevens T; Westerman L; Bressler D; van Schalkwyk E; Bressler C; Ugwu K; Mwangi C; Opio JP; Nkodyo J; Mwangi JW; Martin MD; Nesby-O'Dell S
    Trop Med Health; 2023 Nov; 51(1):65. PubMed ID: 37990251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparing two sample pooling strategies for SARS-CoV-2 RNA detection for efficient screening of COVID-19.
    Chen F; Geng Z; Wang J; Liuchang W; Huang D; Xu Y; Wang Z; Wang L
    J Med Virol; 2021 May; 93(5):2805-2809. PubMed ID: 33107614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of lockdown on Covid-19 case fatality rate and viral mutations spread in 7 countries in Europe and North America.
    Pachetti M; Marini B; Giudici F; Benedetti F; Angeletti S; Ciccozzi M; Masciovecchio C; Ippodrino R; Zella D
    J Transl Med; 2020 Sep; 18(1):338. PubMed ID: 32878627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of the US president's emergency plan for AIDS relief (PEPFAR) HIV and AIDS program on the Nigerian health system.
    Odekunle FF; Odekunle RO
    Pan Afr Med J; 2016; 25():143. PubMed ID: 28292105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Considerations for the selection of tests for SARS-CoV-2 molecular diagnostics.
    Erbak Yılmaz H; Iscan E; Oz O; Batur T; Erdoğan A; Kılıç S; Mutlu Z; Yılmaz M; Spring KJ
    Mol Biol Rep; 2022 Oct; 49(10):9725-9735. PubMed ID: 35441938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular diagnostics of SARS-CoV-2: Findings of an international survey.
    Vacaflores Salinas A; Ashavaid T; Payne DA; Linder MW; Baluchova K; Pan S; Huggett J; Ahmad-Nejad P;
    Clin Chim Acta; 2022 Jun; 531():237-242. PubMed ID: 35413298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.